文献速递泌尿生殖腹部CTMRUS

门静脉期CT上10-40 mm、21-39 HU的偶发均匀肾肿块的临床重要性:一项12机构回顾性队列研究

Clinical Importance of Incidental Homogeneous Renal Masses That Measure 10-40 mm and 21-39 HU at Portal Venous Phase CT: A 12-Institution Retrospective Cohort Study.
PubMed 文献 · AJR Am J Roentgenol · 2020-08-26

该12机构回顾性队列研究评估门静脉期CT偶发10-40 mm、21-39 HU均匀肾肿块的临床重要性,346个有参考标准的肿块中无一具有临床重要性(0%;95%CI 0-0.9%),支持Bosniak分类2019版将需额外影像检查的阈值从>20 HU提高至>30 HU。

要点

  • 门静脉期CT上10-40 mm、21-39 HU的均匀肾肿块常见(占患者4.2%),且极可能为良性。
  • 346个有参考标准的肿块中临床重要者为零(0%;95%CI 0-0.9%)。
  • 研究结果支持Bosniak分类2019版将额外影像检查阈值从>20 HU提高至>30 HU。

核心结论

  • 门静脉期CT上偶发的小(10-40 mm)均匀肾肿块(21-39 HU)常见且极可能为良性,支持Bosniak分类2019版将需额外影像检查的衰减阈值从>20 HU提高至>30 HU。

研究设计与样本

  • 12机构回顾性队列研究,纳入因非肾脏指征行门静脉期CT的成人患者,各机构首例CT日期范围为2008年1月1日至2014年1月1日;评估12,167份连续门静脉期CT报告,对4,529份描述局灶性肾肿块者的图像进行回顾;参考标准为肾脏肿块协议CT或MRI、超声证实为明确良性囊肿或实性肿块、单期增强CT或平扫MRI显示5年及以上无生长或形态变化、或5年及以上临床随访;300例患者共346个肿块有参考标准;95%CI采用二项精确法计算。

诊断标准与关键数值

  • 符合条件的肿块为10-40 mm、边界清晰、主观均匀且21-39 HU;实性无宏观脂肪、Bosniak IIF/III/IV或证实为恶性者视为具有临床重要性;有参考标准的346个肿块中临床重要者为0%(95%CI 0-0.9%);平均肿块大小17 mm;72%(248/346)为21-30 HU,28%(98/346)为31-39 HU。

临床应用与阅片要点

  • 作者结论支持Bosniak分类2019版将门静脉期CT上需额外影像检查的均匀肾肿块衰减阈值从>20 HU提高至>30 HU。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND. Incidental homogeneous renal masses are frequently encountered at portal venous phase CT. The American College of Radiology Incidental Findings Committee's white paper on renal masses recommends additional imaging for incidental homogeneous renal masses greater than 20 HU, but single-center data and the Bosniak classification version 2019 suggest the optimal attenuation threshold for detecting solid masses should be higher. OBJECTIVE. The purpose of this article is to determine the clinical importance of small (10-40 mm) incidentally detected homogeneous renal masses measuring 21-39 HU at portal venous phase CT. METHODS. We performed a 12-institution retrospective cohort study of adult patients who underwent portal venous phase CT for a nonrenal indication. The date of the first CT at each institution ranged from January 1, 2008, to January 1, 2014. Consecutive reports from 12,167 portal venous phase CT examinations were evaluated. Images were reviewed for 4529 CT examinations whose report described a focal renal mass. Eligible masses were 10-40 mm, well-defined, subjectively homogeneous, and 21-39 HU. Of these, masses that were shown to be solid without macroscopic fat; classified as Bosniak IIF, III, or IV; or confirmed to be malignant were considered clinically important. The reference standard was renal mass protocol CT or MRI, ultrasound of definitively benign cysts or solid masses, single-phase contrast-enhanced CT or unenhanced MRI showing no growth or morphologic change for 5 years or more, or clinical follow-up 5 years or greater. A reference standard was available for 346 masses in 300 patients. The 95% CIs were calculated using the binomial exact method. RESULTS. Eligible masses were identified in 4.2% of patients (514/12,167; 95% CI, 3.9-4.6%). Of 346 masses with a reference standard, none were clinically important (0%; 95% CI, 0-0.9%). Mean mass size was 17 mm; 72% (248/346) measured 21-30 HU, and 28% (98/346) measured 31-39 HU. CONCLUSION. Incidental small homogeneous renal masses measuring 21-39 HU at portal venous phase CT are common and highly likely benign. CLINICAL IMPACT. The change in attenuation threshold signifying the need for additional imaging from greater than 20 HU to greater than 30 HU proposed by the Bosniak classification version 2019 is supported.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Corwin MT, Altinmakas E, Asch D, et al. Clinical Importance of Incidental Homogeneous Renal Masses That Measure 10-40 mm and 21-39 HU at Portal Venous Phase CT: A 12-Institution Retrospective Cohort Study. AJR Am J Roentgenol. 2020. PMID: 32845714. doi:10.2214/AJR.20.24245

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。